Skip to main content
TipRanks
Go Ultimate75% OFF

CANbridge Pharmaceuticals Inc. (1228) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

CANbridge Pharmaceuticals Inc. has a market cap or net worth of HKD 968.31M. The enterprise value is HKD 1.45B.

Market Cap
HKD 968.31M
Enterprise Value
HKD 1.45B

Share Statistics

CANbridge Pharmaceuticals Inc. has 597,723,300 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
597,723,300
Owned by Insiders
―
Owned by Institutions
0.18%

Financial Efficiency

CANbridge Pharmaceuticals Inc.’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is 32.86%.

Return on Equity (ROE)
-0.04
Return on Assets (ROA)
0.09
Return on Invested Capital (ROIC)
32.86%
Return on Capital Employed (ROCE)
0.32
Revenue Per Employee
1.28M
Profits Per Employee
379.95K
Employee Count
39
Asset Turnover
0.30
Inventory Turnover
0.65

Valuation Ratios

The current PE Ratio of CANbridge Pharmaceuticals Inc. is -8.72. CANbridge Pharmaceuticals Inc.’s PEG ratio is -0.03.

PE Ratio
-8.72
PS Ratio
10.50
PB Ratio
-3.96
Price to FCF
-5.22
Price to Operating Cash Flow
-6.93
PEG Ratio
-0.03

Income Statement

In the last 12 months, CANbridge Pharmaceuticals Inc. had revenue of 49.98M and earned 14.82M in profits. Earnings per share was 0.03.

Revenue
49.98M
Gross Profit
36.55M
Operating Income
-92.70M
Pretax Income
14.82M
Net Income
14.82M
EBITDA
-80.55M
Earnings Per Share (EPS)
0.03

Cash Flow

In the last 12 months, operating cash flow was -111.98M and capital expenditures -42,000, giving a free cash flow of -112.02M billion.

Operating Cash Flow
-111.98M
Free Cash Flow
-112.02M
Free Cash Flow per Share
-0.20

Dividends & Yields

CANbridge Pharmaceuticals Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-19.17%
Earnings Yield
-10.50%

Stock Price Statistics

Beta
0.49
52-Week Price Change
-22.12%
50-Day Moving Average
1.86
200-Day Moving Average
2.19
Relative Strength Index (RSI)
37.07
Average Volume (3m)
659.13K

Important Dates

CANbridge Pharmaceuticals Inc. upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 31, 2026
Next Earnings Date
Apr 01, 2027
Ex-Dividend Date
―

Financial Position

CANbridge Pharmaceuticals Inc. as a current ratio of 0.24, with Debt / Equity ratio of -4.71%

Current Ratio
0.24
Quick Ratio
0.20
Debt to Market Cap
0.01
Net Debt to EBITDA
0.63
Interest Coverage Ratio
-42.67

Taxes

In the past 12 months, CANbridge Pharmaceuticals Inc. has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

CANbridge Pharmaceuticals Inc. EV to EBITDA ratio is -5.98, with an EV/FCF ratio of -4.69.

EV to Sales
9.43
EV to EBITDA
-5.98
EV to Free Cash Flow
-4.69
EV to Operating Cash Flow
-4.69

Balance Sheet

CANbridge Pharmaceuticals Inc. has HKD 88.10M in cash and marketable securities with HKD 28.81M in debt, giving a net cash position of HKD 59.29M billion.

Cash & Marketable Securities
HKD 88.10M
Total Debt
HKD 28.81M
Net Cash
HKD 59.29M
Net Cash Per Share
HKD 0.10
Tangible Book Value Per Share
-HKD 0.43

Margins

Gross margin is 71.47%, with operating margin of -177.65%, and net profit margin of -146.41%.

Gross Margin
71.47%
Operating Margin
-177.65%
Pretax Margin
-146.41%
Net Profit Margin
-146.41%
EBITDA Margin
-157.69%
EBIT Margin
-177.65%

Analyst Forecast

The average price target for CANbridge Pharmaceuticals Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-8.00%
EPS Growth Forecast
51.26%

Scores

Smart Score
4
AI Score
49